Prestige Wealth Management Group’s Tandem Diabetes Care TNDM Stock Holding History

Prestige Wealth Management Group’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-65	Closed	-$790	–	1031
2025 Q3	$790	Hold	65	–	–	﹤0.01%	888
2025 Q2	$1.21K	Buy	65 +2	+3%	+$40	﹤0.01%	828
2025 Q1	$1.21K	Buy	63 +35	+125%	+$1.02K	﹤0.01%	829
2024 Q4	$1.01K	Buy	+28	New	+$947	﹤0.01%	879
2023 Q3	–	Sell	-24	Closed	-$589	–	1090
2023 Q2	$589	Sell	24 -1	-4%	-$32	﹤0.01%	967
2023 Q1	$1.02K	Buy	+25	New	+$1.03K	﹤0.01%	892
2022 Q4	–	Sell	-11	Closed	-$1K	–	1188
2022 Q3	$1K	Sell	11 -12	-52%	-$658	﹤0.01%	927
2022 Q2	$1K	Buy	+23	New	+$1.89K	﹤0.01%	933

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Prestige Wealth Management Group's TNDM Position: Q4 2025 in Review

Prestige Wealth Management Group sold out of Tandem Diabetes Care (TNDM) in Q4 2025, closing a stake of 65 shares — an estimated $790 sold.

Prestige Wealth Management Group first reported a position in TNDM in Q2 2022 and held it in 8 quarters. The position peaked at $1.21K in Q2 2025. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2025.

Prestige Wealth Management Group reported no remaining Tandem Diabetes Care position as of Q4 2025 after selling out during the quarter.
Prestige Wealth Management Group sold 65 Tandem Diabetes Care shares in Q4 2025, an estimated $790.
Prestige Wealth Management Group first reported a position in Tandem Diabetes Care in Q2 2022 and held it in 8 quarters.
Prestige Wealth Management Group's Tandem Diabetes Care position peaked at $1.21K in Q2 2025.
268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2025.

Based on Prestige Wealth Management Group's 13F filing for Q4 2025, filed 11 Feb 2026.